Trial · NCT04322682
Results by group34
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 34
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants Who Died or Were Hospitalized Due to COVID-19 Infection in the 30 Days Following Randomization. | Colchicine | 104 | Participants | ||
| Number of Participants Who Died or Were Hospitalized Due to COVID-19 Infection in the 30 Days Following Randomization. | Placebo | 131 | Participants | ||
| Number of Deaths in the 30 Days Following Randomization. | Colchicine | 5 | Participants | ||
| Number of Deaths in the 30 Days Following Randomization. | Placebo | 9 | Participants | ||
| Number of Participants Who Were Hospitalized Due to COVID-19 Infection in the 30 Days Following Randomization. | Colchicine | 101 | Participants | ||
| Number of Participants Who Were Hospitalized Due to COVID-19 Infection in the 30 Days Following Randomization. | Placebo | 128 | Participants | ||
| Number of Participants Who Required Mechanical Ventilation in the 30 Days Following Randomization. | Colchicine | 11 | Participants | ||
| Number of Participants Who Required Mechanical Ventilation in the 30 Days Following Randomization. | Placebo | 21 | Participants | ||
| Number of Participants Who Died or Were Hospitalized Due to COVID-19 Infection in the 30 Days Following Randomization in the Subgroup of Patients With PCR-confirmed COVID-19. | Colchicine | 96 | Participants | ||
| Number of Participants Who Died or Were Hospitalized Due to COVID-19 Infection in the 30 Days Following Randomization in the Subgroup of Patients With PCR-confirmed COVID-19. | Placebo | 126 | Participants | ||
| Number of Participants Who Died or Were Hospitalized Due to COVID-19 Infection in the 30 Days Following Randomization by Sex | Colchicine | Male | 58 | Participants | |
| Number of Participants Who Died or Were Hospitalized Due to COVID-19 Infection in the 30 Days Following Randomization by Sex | Placebo | Male | 90 | Participants | |
| Number of Participants Who Died or Were Hospitalized Due to COVID-19 Infection in the 30 Days Following Randomization by Sex | Colchicine | Female | 46 | Participants | |
| Number of Participants Who Died or Were Hospitalized Due to COVID-19 Infection in the 30 Days Following Randomization by Sex | Placebo | Female | 41 | Participants | |
| Number of Participants Who Died or Were Hospitalized Due to COVID-19 Infection in the 30 Days Following Randomization by Race | Colchicine | American Indian or Alaska Native | 1 | Participants | |
| Number of Participants Who Died or Were Hospitalized Due to COVID-19 Infection in the 30 Days Following Randomization by Race | Placebo | American Indian or Alaska Native | 2 | Participants | |
| Number of Participants Who Died or Were Hospitalized Due to COVID-19 Infection in the 30 Days Following Randomization by Race | Colchicine | Asian | 1 | Participants | |
| Number of Participants Who Died or Were Hospitalized Due to COVID-19 Infection in the 30 Days Following Randomization by Race | Placebo | Asian | 3 | Participants | |
| Number of Participants Who Died or Were Hospitalized Due to COVID-19 Infection in the 30 Days Following Randomization by Race | Colchicine | Black | 3 | Participants | |
| Number of Participants Who Died or Were Hospitalized Due to COVID-19 Infection in the 30 Days Following Randomization by Race | Placebo | Black | 6 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04322682/results